Internal Medicine Alert - November 30, 2007

Target Audience:

This activity is intended for the internist and family practitioner.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Executive Editor
Stephen A. Brunton, MD

Clinical Professor
University of California, Irvine

Associate Editors
Barbara A. Phillips, MD, MSPH
Professor of Medicine
University of Kentucky
Director, Sleep Disorders Center
Samaritan Hospital, Lexington

William T. Elliott, MD, FACP
Chair, Formulary Committee
Northern California Kaiser Permanente
Asst. Clinical Professor of Medicine
University of California
San Francisco

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida
Gainesville

Peer Reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY

Authors
Frank W. Ling, MD

Clinical Professor
Dept. of Obstetrics and Gynecology
Vanderbilt University School of Medicine, Nashville

Michael H. Crawford, MD
Professor of Medicine
Chief of Cardiology
University of California San Francisco

Jonathan Abrams, MD
Professor of Medicine
Division of Cardiology
University of New Mexico

Subjects:

  • The List of Potential Benefits of Statins Grows
  • Warfarin vs Aspirin for Atrial Fibrillation in the Elderly
  • Revascularization for Stable Coronary Artery Disease
  • Can Clinical Empathy Be Taught?
  • Doripenem Injection (Doribax™)
  • Clinical Briefs by Louis Kuritzky, MD

Objectives:

  • describe new findings in differential diagnosis and treatment of various diseases
  • describe controversies, advantages, and disadvantages of those advances
  • describe cost-effective treatment regimens
  • describe the pros and cons of new screening procedures.

Financial Disclosure:

Internal Medicine Alert's editor, Stephen Brunton, MD, is a consultant for Abbott, Amylin, Boehringer Ingelheim, Eli Lilly, Endo, Novartis, and Novo Nordisk. Author Frank W. Ling, MD, Associate editor Barbara A. Phillips, MD, MSPH, William T. Elliott, MD, FACP, James Chan, PharmD, PhD and peer reviewer Gerald Roberts, MD, report no financial relationships to this field of study. Author Michael H. Crawford, MD is on the speaker's bureau for Pfizer. Author Jonathan Abrams, MD serves on the speaker's bureau for Merck, Pfizer, and Parke-Davis. Associate editor Louis Kuritzky, MD is a consultant for GlaxoSmithKline and is on the speaker's bureau of GlaxoSmithKline, 3M, Wyeth-Ayerst, Pfizer, Novartis, Bristol-Myers Squibb, AstraZeneca, Jones Pharma, and Boehringer Ingelheim.

Copyright 2007 AHC Media. All rights reserved.